サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1564102

心臓血管インプラントの世界市場

Cardiovascular Implants

出版日
ページ情報
英文 188 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.64円
心臓血管インプラントの世界市場
出版日: 2024年09月01日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 188 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

心臓血管インプラントの世界市場は2030年までに435億米ドルに達する見込み

2023年に311億米ドルと推定された心臓血管インプラントの世界市場は、2023～2030年の分析期間においてCAGR 4.9%で成長し、2030年には435億米ドルに達すると予測されます。本レポートで分析したセグメントの1つであるステントは、CAGR 5.5%を記録し、分析期間終了時には187億米ドルに達すると予測されます。ICDセグメントの成長率は、分析期間でCAGR 3.9％と推定されます。

米国市場は85億米ドル、中国はCAGR4.5％で成長予測

米国の心臓血管インプラント市場は、2023年に85億米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに68億米ドルの市場規模に達すると予測され、分析期間2023-2030年のCAGRは4.5%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ4.8%と3.7%と予測されています。欧州では、ドイツがCAGR 3.9%で成長すると予測されています。

世界の心臓血管インプラント市場- 主要動向と促進要因のまとめ

心臓血管インプラントは心臓疾患の治療をどのように変革しているか？

心臓血管インプラントは、損傷した心血管系構造をサポートしたり置き換えたりすることで、心臓に関連するさまざまな症状を治療・管理するために設計された特殊な医療機器です。これらの機器には、異常な心臓のリズム（不整脈）を調整するペースメーカー、適切な血流を維持するために動脈の開口部を維持するステント、心臓内の疾患または機能不全の弁を置換する心臓弁など、さまざまなツールが含まれます。その他の重要な心臓血管インプラントの種類には、生命を脅かす不整脈を監視して修正する植え込み型除細動器（ICD）や、弱った心臓が全身に血液を送り出すのを助ける補助人工心臓（VAD）などがあります。心臓血管インプラントの重要性は、最も重篤で生命を脅かす心臓病のいくつかに対処できることに由来します。例えば、ペースメーカーやICDは、心臓の鼓動が速すぎたり、遅すぎたり、不規則になったりする不整脈を患っている患者に使用され、突然の心停止を防ぐのに役立ちます。ステントは、冠動脈が閉塞して心臓発作を引き起こす冠動脈疾患患者の命を救うものです。ステントは動脈を開いた状態に保つことで、心筋への継続的な血流を確保し、重篤な合併症を予防します。同様に、心臓弁インプラントは、機械的であれ生物学的であれ、狭窄（狭窄）または漏出（逆流）した弁を置換するために使用され、心臓が効率的な血液循環を維持するのを助けます。心不全、冠動脈疾患、弁膜症などの心臓疾患が蔓延するにつれて、心臓血管インプラントは、そうしなければ生活の質が著しく制限され、あるいは早死にさえ直面する患者にとって、最も効果的で信頼できる治療選択肢の一つとして浮上してきました。これらのインプラントは、正常な心臓機能を回復させたり、機能不全に陥った心臓をサポートすることで、息切れ、胸痛、疲労感などの症状を大幅に軽減し、患者が日常生活に復帰できるようサポートします。

技術はどのように心臓血管インプラントを向上させたか？

技術の進歩は、心臓血管インプラントの有効性、安全性、耐久性を大幅に向上させ、より信頼性が高く、より多くの患者さんが利用できるようになりました。最も重要な技術革新のひとつは、小型化され、侵襲の少ない装置の開発です。例えば、最新のペースメーカーは以前のものよりもはるかに小型化され、侵襲的な手術を必要とせずに植え込むことができるようになったため、回復に要する時間や合併症のリスクが大幅に軽減されました。同様に、薬剤溶出ステントは、物理的に血管をサポートするだけでなく、時間の経過とともに動脈が再び狭くなるのを防ぐために薬剤を放出するように開発されました。心臓弁置換術の分野では、経カテーテル弁移植術が従来の開心術に代わる低侵襲手術として登場し、リスクの高い患者が大手術に伴うリスクを負うことなく救命のための移植を受けられるようになった。さらに、生体適合性材料の進歩により、インプラントの耐久性が向上し、人体との一体感が高まったため、拒絶反応の可能性が減少し、長期的な転帰が改善されました。ウェアラブル技術と遠隔監視システムは現在、多くのインプラントと統合されており、ヘルスケアプロバイダーは患者の心機能をリアルタイムで監視し、必要に応じて治療計画を遠隔で調整することができます。これにより、問題発生時の早期介入が可能になり、患者ケアは大幅に改善されました。さらに、人工知能と機械学習がこれらの機器に組み込まれつつあり、患者のデータを分析し、重大な健康事象につながる前に異常を検出することで、合併症を予測・予防する可能性を提供しています。このような技術革新は、心血管治療の展望を再構築し、インプラントをこれまで以上に安全で、より効果的で、より患者に優しいものにしています。

心臓血管インプラント市場を形成している動向は？

医療技術の進歩、患者層の変化、ヘルスケアプラクティスの進化を反映し、いくつかの主な動向が心臓血管インプラント市場の成長と開拓を促進しています。最も重要な動向の一つは、低侵襲手術に対する需要の高まりです。従来の手術に伴う合併症や回復時間を避けるため、より侵襲性の低い選択肢を求める患者やヘルスケアプロバイダーが増える中、カテーテルや小切開で治療が受けられる心臓血管インプラントの人気が高まっています。この動向は、特に経カテーテル的大動脈弁置換術（TAVR）の利用が増加していることに顕著です。TAVRは、重度の大動脈弁狭窄症の患者が開心術を受けることなく、救命のための弁移植を受けられるようにするものです。市場を形成するもう1つの大きな動向は、人口の高齢化と肥満、糖尿病、高血圧などの生活習慣病の増加による心血管疾患の有病率の増加です。心臓病患者の数が増え続けるにつれ、これらの疾患を治療するための心臓血管インプラントに対するニーズも高まっています。この需要は、より個別化されたプロアクティブな治療を可能にする患者モニタリングとデータ分析の進歩によっても促進されています。臨床医がインプラントの性能をリアルタイムで追跡できる遠隔モニタリング技術はますます一般的になりつつあり、必要に応じて迅速な調整や介入が可能になっています。AIや機械学習をインプラント機器に組み込む動向も、大きな影響を及ぼしています。これらの技術により、デバイスは変化する患者の状態に適応し、潜在的な問題を予測し、リアルタイムで治療を最適化できるようになり、よりスマートで効率的なものになります。さらに、生分解性ステントやその他の一時的な心臓血管インプラントの開発への関心も高まっており、これらのステントは、その機能を発揮した後、自然に溶解し、さらなる外科的介入の必要性を減らすことができます。このような動向が進化し続けるにつれて、様々な心臓疾患の治療における心臓血管インプラントの機能と用途がさらに拡大すると思われます。

心臓血管インプラント市場の成長を促進する要因は？

心臓血管インプラント市場の成長は、技術の進歩、人口動態の変化、ヘルスケア動向の進化に関連するいくつかの要因によって牽引されています。最も顕著な促進要因の1つは、世界の心血管疾患の罹患率の上昇で、特に高齢化が進み、糖尿病、高血圧、肥満などの危険因子を持つ患者が増加しています。心臓疾患の長期管理が必要な患者が増えるにつれ、ペースメーカー、ステント、人工弁などの心臓血管インプラントに対する需要は増加の一途をたどっています。技術革新も主要な成長要因となっています。経カテーテル弁置換術やリードレスペースメーカーなどの低侵襲インプラント治療が開発されたことで、特に従来の手術を受けられない高リスク患者の間で、これらの治療の対象となる患者層が広がっています。もう一つの重要な推進力は、植込み型機器への遠隔モニタリングとAIの統合です。これらの進歩により、リアルタイムのデータ追跡と予測分析が可能になり、ヘルスケアプロバイダーは患者の状態を継続的に監視し、治療計画をタイムリーに調整することができます。このようなプロアクティブなアプローチによる心臓疾患の管理は、患者の予後を改善し、緊急介入や病院での再入院の必要性を低減します。さらに、患者に合わせた治療計画や個別化医療への注目の高まりは、個々の患者のニーズに合わせたインプラントの市場開拓につながり、市場の成長をさらに後押ししています。先進医療技術へのアクセス向上を目指した規制当局の承認や政府の取り組みも、心臓血管インプラント市場の拡大に寄与しています。北米や欧州などの地域では、規制プロセスの合理化により、新しい最先端のインプラントの臨床へのイントロダクションが加速しています。さらに、新興市場におけるヘルスケア支出の増加は、高度な心血管治療へのアクセスを改善し、これらの地域におけるインプラントの採用を促進しています。最後に、短期的な治療よりも長期的な患者の転帰を重視する価値ベースのヘルスケアへのシフトが、耐久性と信頼性の高い心臓血管インプラントの使用を奨励し、市場の成長をさらに後押ししています。

調査対象企業の例（注目の29社）

  • Abbott Laboratories
  • AMG International
  • B. Braun Melsungen AG
  • Biotronik SE & Co. KG
  • Boston Scientific Corporation
  • Cardiac Dimensions Pty. Ltd.
  • Cardiac Science Corporation
  • Edwards Lifesciences Corporation
  • Japan Lifeline Co., Ltd.
  • Medtronic PLC
  • QualiMed Innovative Medizinprodukte GmbH

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • その他欧州
  • アジア太平洋
  • その他の地域

第4章 競合

目次
Product Code: MCP10903

Global Cardiovascular Implants Market to Reach US$43.5 Billion by 2030

The global market for Cardiovascular Implants estimated at US$31.1 Billion in the year 2023, is expected to reach US$43.5 Billion by 2030, growing at a CAGR of 4.9% over the analysis period 2023-2030. Stents, one of the segments analyzed in the report, is expected to record a 5.5% CAGR and reach US$18.7 Billion by the end of the analysis period. Growth in the ICD segment is estimated at 3.9% CAGR over the analysis period.

The U.S. Market is Estimated at US$8.5 Billion While China is Forecast to Grow at 4.5% CAGR

The Cardiovascular Implants market in the U.S. is estimated at US$8.5 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$6.8 Billion by the year 2030 trailing a CAGR of 4.5% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 4.8% and 3.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.9% CAGR.

Global Cardiovascular Implants Market - Key Trends and Drivers Summarized

How Are Cardiovascular Implants Transforming the Treatment of Heart Conditions?

Cardiovascular implants are specialized medical devices designed to treat and manage a wide range of heart-related conditions by either supporting or replacing damaged cardiovascular structures. These devices include a variety of tools such as pacemakers, which help regulate abnormal heart rhythms (arrhythmias), stents that keep arteries open to maintain proper blood flow, and heart valves that replace diseased or malfunctioning valves within the heart. Other important types of cardiovascular implants include implantable cardioverter defibrillators (ICDs), which monitor and correct life-threatening irregular heartbeats, and ventricular assist devices (VADs), which help a weakened heart pump blood throughout the body. The critical importance of cardiovascular implants stems from their ability to address some of the most severe and life-threatening heart conditions. For example, pacemakers and ICDs are used in patients suffering from arrhythmias, where the heart beats too fast, too slow, or irregularly, and can help prevent sudden cardiac arrest. Stents are lifesaving in cases of coronary artery disease, where blocked arteries can lead to heart attacks. By keeping these arteries open, stents ensure continuous blood flow to the heart muscle, preventing severe complications. Similarly, heart valve implants, whether mechanical or biological, are used to replace valves that are either narrowed (stenosis) or leaky (regurgitation), helping the heart to maintain efficient blood circulation. As heart conditions like heart failure, coronary artery disease, and valve disorders become more prevalent, cardiovascular implants have emerged as one of the most effective and reliable treatment options for patients who would otherwise face severe limitations in quality of life, or even premature death. By restoring normal heart function or supporting a failing heart, these implants help patients return to their daily activities with a significant reduction in symptoms like shortness of breath, chest pain, or fatigue.

How Has Technology Enhanced Cardiovascular Implants?

Technological advancements have greatly enhanced the effectiveness, safety, and durability of cardiovascular implants, making them more reliable and accessible for a broader range of patients. One of the most significant innovations has been the development of miniaturized, less invasive devices. For example, modern pacemakers are much smaller than their predecessors and can now be implanted without the need for invasive surgery, significantly reducing recovery times and the risk of complications. Similarly, drug-eluting stents have been developed to not only physically support blood vessels but also release medication to prevent the re-narrowing of arteries over time. In the field of heart valve replacement, transcatheter valve implantation has emerged as a minimally invasive alternative to traditional open-heart surgery, allowing high-risk patients to receive life-saving implants without the risks associated with major surgery. Additionally, advancements in biocompatible materials have made implants more durable and better integrated with the human body, reducing the chances of rejection and improving long-term outcomes. Wearable technology and remote monitoring systems are now integrated with many implants, allowing healthcare providers to monitor a patient's heart function in real time and adjust treatment plans remotely if necessary. This has significantly improved patient care by enabling early intervention when problems arise. Furthermore, artificial intelligence and machine learning are being incorporated into these devices, offering the potential to predict and prevent complications by analyzing patient data and detecting irregularities before they lead to serious health events. These innovations are reshaping the landscape of cardiovascular care, making implants safer, more effective, and more patient-friendly than ever before.

What Trends Are Shaping the Cardiovascular Implants Market?

Several key trends are driving the growth and development of the cardiovascular implants market, reflecting advancements in medical technology, changing patient demographics, and evolving healthcare practices. One of the most important trends is the increasing demand for minimally invasive procedures. As more patients and healthcare providers seek less invasive options to avoid the complications and recovery time associated with traditional surgeries, cardiovascular implants that can be delivered via catheters or small incisions are becoming more popular. This trend is particularly evident in the rising use of transcatheter aortic valve replacement (TAVR) procedures, which allow patients with severe aortic stenosis to receive life-saving valve implants without open-heart surgery. Another major trend shaping the market is the growing prevalence of cardiovascular diseases, driven by aging populations and the rise in lifestyle-related conditions such as obesity, diabetes, and hypertension. As the number of patients with heart disease continues to rise, so does the need for cardiovascular implants to treat these conditions. This demand is also fueled by advancements in patient monitoring and data analytics, which enable more personalized and proactive care. Remote monitoring technologies that allow clinicians to track the performance of implants in real-time are becoming increasingly common, allowing for quicker adjustments and interventions if necessary. The trend towards integrating AI and machine learning into implantable devices is also having a profound impact. These technologies allow devices to adapt to changing patient conditions, predict potential problems, and optimize therapy in real-time, making them smarter and more efficient. Moreover, there is growing interest in developing biodegradable stents and other temporary cardiovascular implants that can perform their function and then naturally dissolve, reducing the need for further surgical interventions. As these trends continue to evolve, they are likely to further expand the capabilities and applications of cardiovascular implants in treating a wide range of heart conditions.

What Factors Are Driving the Growth of the Cardiovascular Implants Market?

The growth in the cardiovascular implants market is driven by several factors linked to technological advancements, demographic shifts, and evolving healthcare trends. One of the most prominent drivers is the rising incidence of cardiovascular diseases globally, particularly in aging populations and among individuals with risk factors such as diabetes, hypertension, and obesity. As more patients require long-term management of heart conditions, the demand for cardiovascular implants, such as pacemakers, stents, and artificial valves, continues to rise. Technological innovations have also been a key growth driver. The development of minimally invasive implant procedures, such as transcatheter valve replacements and leadless pacemakers, has broadened the patient pool eligible for these treatments, particularly among high-risk individuals who cannot undergo traditional surgery. Another significant driver is the integration of remote monitoring and AI into implantable devices. These advancements allow for real-time data tracking and predictive analytics, enabling healthcare providers to monitor a patient’s condition continuously and make timely adjustments to treatment plans. This proactive approach to managing heart conditions improves patient outcomes and reduces the need for emergency interventions or hospital readmissions. Additionally, the increased focus on patient-specific treatment plans and personalized medicine has led to the development of implants tailored to individual patient needs, further boosting market growth. Regulatory approvals and government initiatives aimed at improving access to advanced medical technologies have also contributed to the expansion of the cardiovascular implants market. In regions such as North America and Europe, streamlined regulatory processes have accelerated the introduction of new, cutting-edge implants into clinical practice. Furthermore, increasing healthcare expenditure in emerging markets has improved access to advanced cardiovascular care, driving the adoption of implants in these regions. Finally, the shift towards value-based healthcare, where the focus is on long-term patient outcomes rather than short-term treatments, has incentivized the use of durable and reliable cardiovascular implants, further propelling market growth.

Select Competitors (Total 29 Featured) -

  • Abbott Laboratories
  • AMG International
  • B. Braun Melsungen AG
  • Biotronik SE & Co. KG
  • Boston Scientific Corporation
  • Cardiac Dimensions Pty. Ltd.
  • Cardiac Science Corporation
  • Edwards Lifesciences Corporation
  • Japan Lifeline Co., Ltd.
  • Medtronic PLC
  • QualiMed Innovative Medizinprodukte GmbH

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Global Economic Update
    • Cardiovascular Implants - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Global Prevalence of Cardiovascular Diseases Spurs Demand for Cardiovascular Implants
    • Advancements in Biocompatible Materials Strengthen the Business Case for Next-Generation Implants
    • Aging Population and Increasing Incidence of Heart Failure Propel Growth of Cardiovascular Implants Market
    • Shift Toward Minimally Invasive Procedures Expands Addressable Market for Advanced Cardiovascular Implants
    • Here's How Wearable Technology and Remote Monitoring Capabilities Drive Adoption of Smart Cardiovascular Implants
    • Growing Adoption of Transcatheter Implant Procedures Spurs Demand for Innovative Cardiovascular Solutions
    • Post-Surgical Monitoring Capabilities Boost Demand for Intelligent Cardiovascular Implants
    • Growing Use of 3D Printing Technology in Cardiovascular Implants Propels Innovation and Market Growth
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Cardiovascular Implants Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Cardiovascular Implants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Cardiovascular Implants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 4: World 16-Year Perspective for Cardiovascular Implants by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 7: World 16-Year Perspective for Stents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for ICD by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for ICD by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for ICD by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Heart Valve by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Heart Valve by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for Heart Valve by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Implanted Cardiac Pacemaker by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Implanted Cardiac Pacemaker by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 16: World 16-Year Perspective for Implanted Cardiac Pacemaker by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for CRT Device by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 18: World Historic Review for CRT Device by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 19: World 16-Year Perspective for CRT Device by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Cardiovascular Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 20: USA Recent Past, Current & Future Analysis for Cardiovascular Implants by Segment - Stents, ICD, Heart Valve, Implanted Cardiac Pacemaker and CRT Device - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 21: USA Historic Review for Cardiovascular Implants by Segment - Stents, ICD, Heart Valve, Implanted Cardiac Pacemaker and CRT Device Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 22: USA 16-Year Perspective for Cardiovascular Implants by Segment - Percentage Breakdown of Value Sales for Stents, ICD, Heart Valve, Implanted Cardiac Pacemaker and CRT Device for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 23: Canada Recent Past, Current & Future Analysis for Cardiovascular Implants by Segment - Stents, ICD, Heart Valve, Implanted Cardiac Pacemaker and CRT Device - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 24: Canada Historic Review for Cardiovascular Implants by Segment - Stents, ICD, Heart Valve, Implanted Cardiac Pacemaker and CRT Device Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 25: Canada 16-Year Perspective for Cardiovascular Implants by Segment - Percentage Breakdown of Value Sales for Stents, ICD, Heart Valve, Implanted Cardiac Pacemaker and CRT Device for the Years 2014, 2024 & 2030
  • JAPAN
    • Cardiovascular Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 26: Japan Recent Past, Current & Future Analysis for Cardiovascular Implants by Segment - Stents, ICD, Heart Valve, Implanted Cardiac Pacemaker and CRT Device - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 27: Japan Historic Review for Cardiovascular Implants by Segment - Stents, ICD, Heart Valve, Implanted Cardiac Pacemaker and CRT Device Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 28: Japan 16-Year Perspective for Cardiovascular Implants by Segment - Percentage Breakdown of Value Sales for Stents, ICD, Heart Valve, Implanted Cardiac Pacemaker and CRT Device for the Years 2014, 2024 & 2030
  • CHINA
    • Cardiovascular Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 29: China Recent Past, Current & Future Analysis for Cardiovascular Implants by Segment - Stents, ICD, Heart Valve, Implanted Cardiac Pacemaker and CRT Device - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 30: China Historic Review for Cardiovascular Implants by Segment - Stents, ICD, Heart Valve, Implanted Cardiac Pacemaker and CRT Device Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 31: China 16-Year Perspective for Cardiovascular Implants by Segment - Percentage Breakdown of Value Sales for Stents, ICD, Heart Valve, Implanted Cardiac Pacemaker and CRT Device for the Years 2014, 2024 & 2030
  • EUROPE
    • Cardiovascular Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 32: Europe Recent Past, Current & Future Analysis for Cardiovascular Implants by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 33: Europe Historic Review for Cardiovascular Implants by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 34: Europe 16-Year Perspective for Cardiovascular Implants by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 35: Europe Recent Past, Current & Future Analysis for Cardiovascular Implants by Segment - Stents, ICD, Heart Valve, Implanted Cardiac Pacemaker and CRT Device - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Europe Historic Review for Cardiovascular Implants by Segment - Stents, ICD, Heart Valve, Implanted Cardiac Pacemaker and CRT Device Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: Europe 16-Year Perspective for Cardiovascular Implants by Segment - Percentage Breakdown of Value Sales for Stents, ICD, Heart Valve, Implanted Cardiac Pacemaker and CRT Device for the Years 2014, 2024 & 2030
  • FRANCE
    • Cardiovascular Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 38: France Recent Past, Current & Future Analysis for Cardiovascular Implants by Segment - Stents, ICD, Heart Valve, Implanted Cardiac Pacemaker and CRT Device - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: France Historic Review for Cardiovascular Implants by Segment - Stents, ICD, Heart Valve, Implanted Cardiac Pacemaker and CRT Device Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: France 16-Year Perspective for Cardiovascular Implants by Segment - Percentage Breakdown of Value Sales for Stents, ICD, Heart Valve, Implanted Cardiac Pacemaker and CRT Device for the Years 2014, 2024 & 2030
  • GERMANY
    • Cardiovascular Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 41: Germany Recent Past, Current & Future Analysis for Cardiovascular Implants by Segment - Stents, ICD, Heart Valve, Implanted Cardiac Pacemaker and CRT Device - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 42: Germany Historic Review for Cardiovascular Implants by Segment - Stents, ICD, Heart Valve, Implanted Cardiac Pacemaker and CRT Device Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: Germany 16-Year Perspective for Cardiovascular Implants by Segment - Percentage Breakdown of Value Sales for Stents, ICD, Heart Valve, Implanted Cardiac Pacemaker and CRT Device for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 44: Italy Recent Past, Current & Future Analysis for Cardiovascular Implants by Segment - Stents, ICD, Heart Valve, Implanted Cardiac Pacemaker and CRT Device - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Italy Historic Review for Cardiovascular Implants by Segment - Stents, ICD, Heart Valve, Implanted Cardiac Pacemaker and CRT Device Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: Italy 16-Year Perspective for Cardiovascular Implants by Segment - Percentage Breakdown of Value Sales for Stents, ICD, Heart Valve, Implanted Cardiac Pacemaker and CRT Device for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Cardiovascular Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 47: UK Recent Past, Current & Future Analysis for Cardiovascular Implants by Segment - Stents, ICD, Heart Valve, Implanted Cardiac Pacemaker and CRT Device - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 48: UK Historic Review for Cardiovascular Implants by Segment - Stents, ICD, Heart Valve, Implanted Cardiac Pacemaker and CRT Device Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: UK 16-Year Perspective for Cardiovascular Implants by Segment - Percentage Breakdown of Value Sales for Stents, ICD, Heart Valve, Implanted Cardiac Pacemaker and CRT Device for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 50: Rest of Europe Recent Past, Current & Future Analysis for Cardiovascular Implants by Segment - Stents, ICD, Heart Valve, Implanted Cardiac Pacemaker and CRT Device - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Rest of Europe Historic Review for Cardiovascular Implants by Segment - Stents, ICD, Heart Valve, Implanted Cardiac Pacemaker and CRT Device Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: Rest of Europe 16-Year Perspective for Cardiovascular Implants by Segment - Percentage Breakdown of Value Sales for Stents, ICD, Heart Valve, Implanted Cardiac Pacemaker and CRT Device for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Cardiovascular Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 53: Asia-Pacific Recent Past, Current & Future Analysis for Cardiovascular Implants by Segment - Stents, ICD, Heart Valve, Implanted Cardiac Pacemaker and CRT Device - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Asia-Pacific Historic Review for Cardiovascular Implants by Segment - Stents, ICD, Heart Valve, Implanted Cardiac Pacemaker and CRT Device Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 55: Asia-Pacific 16-Year Perspective for Cardiovascular Implants by Segment - Percentage Breakdown of Value Sales for Stents, ICD, Heart Valve, Implanted Cardiac Pacemaker and CRT Device for the Years 2014, 2024 & 2030
  • REST OF WORLD
    • TABLE 56: Rest of World Recent Past, Current & Future Analysis for Cardiovascular Implants by Segment - Stents, ICD, Heart Valve, Implanted Cardiac Pacemaker and CRT Device - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Rest of World Historic Review for Cardiovascular Implants by Segment - Stents, ICD, Heart Valve, Implanted Cardiac Pacemaker and CRT Device Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 58: Rest of World 16-Year Perspective for Cardiovascular Implants by Segment - Percentage Breakdown of Value Sales for Stents, ICD, Heart Valve, Implanted Cardiac Pacemaker and CRT Device for the Years 2014, 2024 & 2030

IV. COMPETITION